Homepage0882 • HKG
add
Tianjin Development Holdings Ltd
Vorige slotkoers
$Â 2,52
Dag-range
$Â 2,50 - $Â 2,52
Jaar-range
$Â 1,77 - $Â 2,98
Beurswaarde
2,70Â mld. HKD
Gem. volume
625,41K
Koers/winst
4,47
Dividendrendement
5,56%
Primaire beurs
HKG
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (HKD) | jun 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 859,29Â mln. | -5,59% |
Bedrijfskosten | 279,00Â mln. | 13,90% |
Netto inkomsten | 172,23Â mln. | 19,57% |
Netto winstmarge | 20,04 | 26,60% |
Winst per aandeel | — | — |
EBITDA | 43,46Â mln. | -57,59% |
Effectief belastingtarief | 11,06% | — |
Balans
Totale activa
Totale passiva
| (HKD) | jun 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 5,61Â mld. | -14,05% |
Totale activa | 22,45Â mld. | 1,42% |
Totale passiva | 4,76Â mld. | -2,03% |
Totaal aandelenvermogen | 17,69 mld. | — |
Uitstaande aandelen | 1,07 mld. | — |
Koers-boekwaardeverhouding | 0,21 | — |
Rendement op activa | -0,06% | — |
Rendement op kapitaal | -0,06% | — |
Kasstroom
Nettomutatie in liquide middelen
| (HKD) | jun 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 172,23Â mln. | 19,57% |
Operationele kasstroom | 45,16Â mln. | 126,10% |
Kasstroom uit beleggingen | -492,62Â mln. | -232,82% |
Kasstroom uit financiering | -85,59Â mln. | -481,40% |
Nettomutatie in liquide middelen | -545,28Â mln. | -77,61% |
Vrije kasstroom | 32,07Â mln. | -52,46% |
Over
Tianjin Development Holdings Limited or Tianjin Development is a conglomerate engaged in container terminal operations, toll roads, water supply, electric utilities, pharmaceuticals and property development in Tianjin, China. In 2005, Tianjin Development split Tianjin Port Development to be listed on the Hong Kong Stock Exchange.
On 22 July 2015, a subsidiary of Tianjin Development agreed to acquire from Tianjin Pharmaceutical Group Co., Ltd. 67% shares of the issued share capital of Thrive Leap Limited at a consideration of RMB 2.3 billion. Thrive Leap Limited indirectly holds approximately 51.36% of the total issued A shares in Tianjin Lisheng Pharmaceutical Co., Ltd., 65% equity interest in Tianjin Yiyao Printing Co., Ltd., and 100% equity interest Tianjin Institute of Pharmaceutical Research Co., Ltd. Wikipedia
Opgericht
9 mei 1997
Website
Werknemers
2.735
